Increasingly, elderly patients undergo anesthesia and surgery. Methadone is a great opioid for perioperative pain management, however, to date there are no pharmacokinetic or pharmacodynamic studies that asses a methadone dose adjustment in the elderly patient. The present study is aimed to characterize the pharmacokinetic and pharmacodynamic age-related changes of methadone in the adult population and further to design reference dosing protocols for intraoperative methadone use according to patient age.
The subjects will be recruited from adult patients who undergo elective laparoscopic abdominal surgery at UC Christus Clinical Hospital (Santiago, de Chile). Patients will be randomly divided into four groups according to the dose of intravenous methadone to be administered during anaesthetic induction. BIS-guided and standard general anaesthesia will be administered with routine monitoring. Methadone will be administered once the patient is intubated and has hemodynamic stability. The only opioids that patients will receive will be remifentanil and methadone. Upon admission to the Post-anesthesia care unit, the patient is given a Patient-Control Analgesia pump for intravenous administration of morphine. Clinic evaluations will be carried out periodically and blood samples for measurement of plasma methadone will be taken at different times. Samples will be analyzed using high-performance liquid chromatography spectrofluorometric method. The data obtained will be collected in a form within the REDCAP application, to subsequently generate an encrypted database. Groups will be compared regarding pain score, drugs used, opioid consumption, side effects, time of recovery, and patient satisfaction. One, two and three-compartment linear models will be used to fit the plasma methadone concentration data over time. Models are parameterized in terms of elimination clearance, compartment distribution clearance, central volume and peripheral volume of distribution, as appropriate. The use of rescue morphine in the Post-anesthesia care unit will be used as a measure to relate the methadone dose (mg/kg) with the analgesic efficacy using an EMAX model. The data will be modelled using NONMEM VII. A proportional term will be used for variability between subjects. Additive and proportional terms will be used to characterize the unknown residual variability. Sample size calculations were estimated using a simulation-based approach and previous work with a similar methodology. To achieve an adequate representation of all age groups 60 patients will be required, distributed among 20 patients between 18 and 40 years, 20 patients between 41 and 65 years, and 20 patients\> 65 years.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Perioperative use of placebo for pain management and remifentanil during the surgery.
Pontificia Universidad Católica de Chile
Santiago, Santiago Metropolitan, Chile
Methadone plasmatic levels Measured by high pressure liquid chromatography
Five venous blood samples will be taken from each patient for methadone plasmatic level analysis. Patients will be randomly divided into two groups with different sample collection times. Group 1 at 0.05, 0.75, 1.5, 6, 18 hours post drug administration and Group 2 at 0.25, 1, 3, 12 and 24 hours.
Time frame: From the first dose up to 24 hours.
Hemodynamics
Non invasive systolic and diastolic blood pressure monitoring (mmHg).
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
Heart Rate
Heart rate (bpm)
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
Pulse oximetry
% oximetry saturation
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs. Then, from the entrance to the recovery room every 30 minutes up to 180 minutes.
BIS
Depth of anesthesia will be recorded with BIS monitor. From 60 - 40
Time frame: Every 5 min. Since entering operating room up to end of anesthesia and leaving to recovery room. In average 2 hrs.
Respiratory rate
bpm
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Numeric Pain Rating Scale
Numeric Pain rating scale in rest and movement, from 0 (no pain) to 10 (maximum pain).
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Nausea or vomiting
Presence of nausea or vomiting in the recovery room.
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Sedation (Ramsay Scale)
Ramsay scale (1-6)
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Respiratory depression
Presence of respiratory depression in the recovery room. (Respiratory rate less than 8 bpm requiring oxygen therapy).
Time frame: Every 30 minutes. Since entering the recovery room up to 180 mins.
Other opioids and pain management drugs used during recovery stay
Name and total doses, including Morphine PCA.
Time frame: Since the admission to the recovery room up to 2 hours.
Intestinal transit recovery
Time to first flatus, fist bowel movement and stool. Presence of abdominal bloating.
Time frame: Since the admission to the recovery room up to 2 hours.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.